CSL Ltd CMXHF:OTCPK

RT Quote | Exchange | USD
Last | 03/02/21 EST
212.87UNCH (UNCH)
52 week range
147.16 - 233.50

...

Loading . . .

KEY STATS

  • Open0.00
  • Day High0.00
  • Day Low0.00
  • Prev Close212.87
  • 52 Week High233.50
  • 52 Week High Date11/24/20
  • 52 Week Low147.16
  • 52 Week Low Date03/18/20
  • Market Cap93,046.96M
  • Shares Out454.97M
  • 10 Day Average Volume338.36
  • Dividend2.05
  • Dividend Yield0.96%
  • Beta
  • 1 Year % Change9.56

RATIOS/PROFITABILITY

  • EPS (TTM)5.86
  • P/E (TTM)36.31
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date03/04/2021
  • Div Amount1.04
  • Split Date-
  • Split Factor-

Latest CSL Ltd News

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
CSL Limited is an Australia-based biotechnology company engaged in the developing and delivering medicines that treat people with rare diseases. It offers treatments for people who are living with conditions in the immunology and neurology; haematology and thrombosis; cardiovascular and metabolic; respiratory, and transplant therapeutic areas. Its segment includes CSL Behring and Seqirus. CSL Behring segment manufactures, markets, and develops plasma therapies (plasma...
Brian McNamee
Non-Executive Chairman
Paul Perreault
Chief Executive Officer
Paul McKenzie Ph.D.
Chief Operating Officer
Joy Linton
Chief Financial Officer
Alan Wills
Executive Vice President
Address
45 Poplar Road,, Parkville
Melbourne, VIC
3052
Australia